Last quarter (Q4 2023), TELA Bio's total revenue was $17.00M, an increase of 46.26% from the same quarter last year. In Q4, TELA Bio's net income was $-12.89M. See TELA Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 58.45M	$ 58.45M	$ 41.42M	$ 29.46M	$ 18.21M	$ 15.45M
Cost of Revenue	$ 14.04M	$ 17.96M	$ 13.57M	-	$ 6.98M	$ 6.17M
Gross Profit	$ 44.41M	$ 40.49M	$ 27.85M	$ 18.81M	$ 11.23M	$ 9.27M
Operating Expense	$ 88.29M	$ 84.19M	$ 66.05M	$ -48.26M	$ 36.51M	$ 28.43M
Operating Income	$ -44.08M	$ -44.08M	$ -39.01M	$ -19.10M	$ -25.27M	$ -19.16M
Net Non Operating Interest Income Expense	$ -5.22M	$ -5.22M	$ -4.05M	$ -3.60M	$ -3.56M	$ -3.61M
Other Income Expense	$ -2.63M	$ -2.63M	$ 2.04M	$ 10.57M	$ 45.00K	$ 346.00K
Pretax Income	$ -46.68M	$ -46.68M	$ -44.29M	$ -33.27M	$ -28.79M	$ -22.43M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -46.66M	$ -46.66M	$ -44.29M	$ -33.27M	$ -28.79M	$ -30.21M
Basic EPS	$ -2.06	$ -2.04	$ -2.72	$ -2.30	$ -2.23	$ -17.10
Diluted EPS	$ -2.06	$ -2.04	$ -2.72	$ -2.30	$ -2.23	$ -17.10
Basic Average Shares	$ 91.47M	$ 22.87M	$ 16.27M	$ 14.47M	$ 12.93M	$ 1.77M
Diluted Average Shares	$ 91.47M	$ 22.87M	$ 16.27M	$ 14.47M	$ 12.93M	$ 1.77M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 102.34M	$ 102.15M	$ 79.62M	$ -48.26M	$ 43.49M	$ 34.61M
Net Income From Continuing And Discontinued Operation	$ -46.66M	$ -46.66M	$ -44.30M	$ -33.27M	$ -28.79M	$ -22.43M
Normalized Income	$ -27.35M	$ -36.85M	$ -34.19M	-	$ -28.79M	$ -22.42M
Interest Expense	-	-	-	-	$ 3.56M	$ 3.61M
EBIT	$ -41.46M	$ -41.46M	$ -40.24M	$ -29.68M	$ -25.23M	$ -18.82M
EBITDA	$ -31.38M	$ -40.66M	$ -39.04M	$ -29.38M	$ -24.70M	$ -18.23M

Currency in USD

TELA Bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing